Related Experiment Video
Updated: Sep 22, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication
Yoichi Miyamoto1, Yumi Itoh2, Tatsuya Suzuki2
1Laboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan. ymiyamoto@nibiohn.go.jp.
Abstract:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ORF6 is an antagonist of interferon (IFN)-mediated antiviral signaling, achieved through the prevention of STAT1 nuclear localization. However, the exact mechanism through which ORF6 prevents STAT1 nuclear trafficking remains unclear. Herein, we demonstrate that ORF6 directly binds to STAT1 with or without IFN stimulation, resulting in the nuclear exclusion of STAT1. ORF6 also recognizes importin α subtypes with different modes, in particular, high affinity to importin α1 but a low affinity to importin α5. Although ORF6 potentially disrupts the importin α/importin β1-mediated nuclear transport, thereby suppressing the nuclear translocation of the other classical nuclear localization signal-containing cargo proteins, the inhibitory effect of ORF6 is modest when compared with that of STAT1. The results indicate that the drastic nuclear exclusion of STAT1 is attributed to the specific binding with ORF6, which is a distinct strategy for the importin α1-mediated pathway. Combined with the results from a newly-produced replicon system and a hamster model, we conclude that SARS-CoV-2 ORF6 acts as a virulence factor via regulation of nucleocytoplasmic trafficking to accelerate viral replication, resulting in disease progression.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ORF6 protein directly binds STAT1, preventing its nuclear entry. This mechanism enhances viral replication and disease progression by disrupting antiviral signaling.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ORF6 protein antagonizes interferon-mediated antiviral signaling by blocking STAT1 nuclear localization.
- The precise mechanism by which ORF6 inhibits STAT1 nuclear trafficking is not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanism of SARS-CoV-2 ORF6 in preventing STAT1 nuclear translocation.
- To investigate the interaction between ORF6, STAT1, and importin α subtypes.
- To evaluate the role of ORF6 in viral pathogenesis.
Main Methods:
- Co-immunoprecipitation assays to demonstrate direct binding of ORF6 and STAT1.
- Analysis of importin α subtype recognition by ORF6.
- Assessment of ORF6's impact on nuclear transport of other proteins.
- Utilizing a SARS-CoV-2 replicon system and a hamster model.
Main Results:
- ORF6 directly binds STAT1, independent of interferon stimulation, causing STAT1 nuclear exclusion.
- ORF6 exhibits differential binding affinities to importin α subtypes, with high affinity for importin α1.
- While ORF6 can interfere with general nuclear transport, its effect on STAT1 is more pronounced due to specific binding.
- ORF6 acts as a virulence factor by regulating nucleocytoplasmic trafficking, promoting viral replication and disease progression.
Conclusions:
- SARS-CoV-2 ORF6 employs a distinct strategy, directly binding STAT1 via the importin α1 pathway, to achieve nuclear exclusion.
- ORF6's regulation of nucleocytoplasmic trafficking is crucial for viral virulence and disease progression.
More Related Videos
09:13Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
09:26Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
Published on: June 6, 2025
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Regulation of Nuclear Protein Sorting
Leaky Scanning
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Viruses with RNA Genomes
Directing Proteins to the Rough Endoplasmic Reticulum